Esperasinc

Shutdown

Website unreachable since Oct 21, 2026

The startup operates a medical technology platform focused on developing an oral investigational medicine that inhibits cancer cell division. This approach aims to provide healthcare professionals with additional treatment options for various cancer indications, ultimately demonstrating clinical proof-of-concept for efficacy in cancer patients.

Traction –/10

Montréal, Canada · HQ

Biotechnology

Updated 5 months ago

Funding

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Features

The startup operates a medical technology platform focused on developing an oral investigational medicine that inhibits cancer cell division. This approach aims to provide healthcare professionals with additional treatment options for various cancer indications, ultimately demonstrating clinical proof-of-concept for efficacy in cancer patients.